Free Trial

Bristol Myers Squibb (BMY) 10K Form and Latest SEC Filings 2026

Bristol Myers Squibb logo
$56.56 -0.39 (-0.69%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$56.55 -0.01 (-0.01%)
As of 05/6/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Bristol Myers Squibb SEC Filings & Recent Activity

Bristol Myers Squibb (NYSE:BMY) has submitted 920+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Bristol Myers Squibb's financial statements. The most recent filing was a Form 4 submitted on May 5, 2026.

Form 4
BRISTOL MYERS SQUIBB CO Reports Ownership Change on May. 5, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Bristol Myers Squibb Files Current Report on Apr. 30, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Bristol Myers Squibb Files Quarterly Report on Apr. 30, 2026

The 10-Q contains Bristol Myers Squibb's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Bristol Myers Squibb SEC Filing History

Browse Bristol Myers Squibb's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/05/2026 4:11 PM
Bristol Myers Squibb (14272) Issuer
Lenkowsky Adam (1975719) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 10:44 AM
Bristol Myers Squibb (14272) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2026 6:01 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 3:15 PM
Bristol Myers Squibb (14272) Filer
Form DEFA14A
04/02/2026 3:24 PM
Arduini Peter J (1323134) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:32 PM
Bristol Myers Squibb (14272) Subject
Elkins David V (1451604) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2026 3:05 PM
Bristol Myers Squibb (14272) Filer
Form 15-12G
03/26/2026 3:44 PM
Bristol Myers Squibb (14272) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/25/2026 4:16 PM
Bristol Myers Squibb (14272) Filer
Form ARS
03/25/2026 3:35 PM
Bristol Myers Squibb (14272) Filer
Form DEFA14A
03/25/2026 3:19 PM
Bristol Myers Squibb (14272) Filer
Form DEF 14A
03/12/2026 3:23 PM
Bristol Myers Squibb (14272) Issuer
Shibutani Hiroshi Chris (2072494) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:24 PM
Bristol Myers Squibb (14272) Issuer
Hickey Benjamin (1753055) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:13 PM
Bristol Myers Squibb (14272) Issuer
Elkins David V (1451604) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:14 PM
BOERNER CHRISTOPHER S. (1543747) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:15 PM
Bristol Myers Squibb (14272) Issuer
Poole Ahn Amanda (2005210) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:16 PM
Bristol Myers Squibb (14272) Issuer
Gallman Cari (1995058) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:17 PM
Bristol Myers Squibb (14272) Issuer
Hoch Lynelle (2005382) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:17 PM
Bristol Myers Squibb (14272) Issuer
Holzer Phil M (2012588) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:18 PM
Bristol Myers Squibb (14272) Issuer
Lenkowsky Adam (1975719) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:19 PM
Bristol Myers Squibb (14272) Issuer
Meyers Gregory Scott (1908769) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 10:35 AM
Bristol Myers Squibb (14272) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2026 6:07 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2026 3:35 PM
Bristol Myers Squibb (14272) Issuer
Vousden Karen H (1723884) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:36 PM
Bristol Myers Squibb (14272) Issuer
YALE PHYLLIS R (1269070) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:39 PM
Bristol Myers Squibb (14272) Issuer
Hickey Benjamin (1753055) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:40 PM
Bristol Myers Squibb (14272) Issuer
Meyers Gregory Scott (1908769) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:18 PM
Arduini Peter J (1323134) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:20 PM
Bhatt Deepak (1934074) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 3:22 PM
Bristol Myers Squibb (14272) Issuer
Haller Julia A (1656082) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 9:20 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2025 3:41 PM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 9:06 AM
Bristol Myers Squibb (14272) Filer
Form CERT
11/10/2025 3:45 PM
BMS Ireland Capital Funding Designated Activity Co (2090756) Filer
Bristol Myers Squibb (14272) Filer
Form 8-A12B
11/05/2025 3:50 PM
Bristol Myers Squibb (14272) Subject
Form FWP
11/04/2025 4:13 PM
Bristol Myers Squibb (14272) Issuer
Shanahan Karin (1917325) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 4:15 PM
Bristol Myers Squibb (14272) Issuer
Meyers Gregory Scott (1908769) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 4:18 PM
BOERNER CHRISTOPHER S. (1543747) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 4:19 PM
Bristol Myers Squibb (14272) Issuer
Lenkowsky Adam (1975719) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2025 5:02 AM
BMS Ireland Capital Funding Designated Activity Co (2090756) Filer
Bristol Myers Squibb (14272) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
11/03/2025 5:09 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 3:11 PM
BMS Ireland Capital Funding Designated Activity Co (2090756) Filer
Bristol Myers Squibb (14272) Filer
Form POSASR
10/31/2025 8:48 AM
Bristol Myers Squibb (14272) Subject
JPMORGAN CHASE & CO (19617) Filed by
JPMORGAN CHASE & CO (19617) Filed by
JPMORGAN CHASE & CO (19617) Filed by
JPMORGAN CHASE & CO (19617) Filed by
Form SCHEDULE 13G/A
10/30/2025 11:04 AM
Bristol Myers Squibb (14272) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2025 6:09 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2025 4:22 PM
Bristol Myers Squibb (14272) Issuer
Gallman Cari (1995058) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 5:15 PM
Bristol Myers Squibb (14272) Issuer
Rice Derica W (1359067) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 5:18 PM
Bristol Myers Squibb (14272) Issuer
Samuels Theodore R. II (1688276) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 5:20 PM
Bristol Myers Squibb (14272) Issuer
YALE PHYLLIS R (1269070) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 5:11 PM
Arduini Peter J (1323134) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 5:14 PM
Bristol Myers Squibb (14272) Issuer
McMullen Michael R. (1418949) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 5:42 PM
Bristol Myers Squibb (14272) Issuer
Short Bartie Wendy (2070839) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 5:46 PM
Bristol Myers Squibb (14272) Issuer
Elkins David V (1451604) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 10:16 AM
Bristol Myers Squibb (14272) Subject
Elkins David V (1451604) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2025 4:58 PM
Bristol Myers Squibb (14272) Issuer
Short Bartie Wendy (2070839) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025 5:01 PM
Bristol Myers Squibb (14272) Issuer
Gallman Cari (1995058) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025 5:15 PM
Bristol Myers Squibb (14272) Issuer
Massacesi Cristian (2080176) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/05/2025 5:16 PM
Bristol Myers Squibb (14272) Issuer
Massacesi Cristian (2080176) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025 11:17 AM
Bristol Myers Squibb (14272) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2025 6:06 AM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2025 3:43 PM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025 4:44 PM
Bristol Myers Squibb (14272) Issuer
Samuels Theodore R. II (1688276) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 4:48 PM
Bristol Myers Squibb (14272) Issuer
Rice Derica W (1359067) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 4:50 PM
Bristol Myers Squibb (14272) Issuer
McMullen Michael R. (1418949) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 4:52 PM
Arduini Peter J (1323134) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 4:41 PM
Bristol Myers Squibb (14272) Issuer
YALE PHYLLIS R (1269070) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:43 PM
BOERNER CHRISTOPHER S. (1543747) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:47 PM
Bristol Myers Squibb (14272) Issuer
Shibutani Hiroshi Chris (2072494) Reporting
Form 3
Initial statement of beneficial ownership of securities  
06/06/2025 1:24 PM
Bristol Myers Squibb (14272) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2025 1:24 PM
Bristol Myers Squibb (14272) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2025 1:25 PM
Bristol Myers Squibb (14272) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/04/2025 4:30 PM
BOERNER CHRISTOPHER S. (1543747) Reporting
Bristol Myers Squibb (14272) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025 4:33 PM
Bristol Myers Squibb (14272) Issuer
Short Bartie Wendy (2070839) Reporting
Form 3
Initial statement of beneficial ownership of securities  
06/04/2025 4:37 PM
Bristol Myers Squibb (14272) Issuer
Short Bartie Wendy (2070839) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025 6:03 PM
Bristol Myers Squibb (14272) Issuer
Hickey Benjamin (1753055) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025 8:10 AM
2seventy bio, Inc. (1860782) Subject
Bristol Myers Squibb (14272) Filed by
Form SC TO-T/A
05/07/2025 4:04 PM
Bristol Myers Squibb (14272) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025 6:57 AM
2seventy bio, Inc. (1860782) Subject
Bristol Myers Squibb (14272) Filed by
Form SC TO-T/A
(Data available from 1/1/2016 forward)

Bristol Myers Squibb SEC Filings - Frequently Asked Questions

Bristol Myers Squibb (BMY) has submitted 920+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Bristol Myers Squibb's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Bristol Myers Squibb's financial statements page.

The most recent filing was a Form 4 submitted on May 5, 2026. This was an insider ownership change filed by 4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:BMY) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners